Clinical Impact and Cost-effectiveness of Xpert MTB/RIF Testing in Hospitalized Patients With Presumptive Pulmonary Tuberculosis in the United States. [electronic resource]
Producer: 20171222Description: 482-489 p. digitalISSN:- 1537-6591
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Cost-Benefit Analysis
- DNA, Bacterial
- Female
- Hospitalization
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Mycobacterium tuberculosis -- genetics
- Nucleic Acid Amplification Techniques -- economics
- Prospective Studies
- Reproducibility of Results
- Sensitivity and Specificity
- Sputum -- microbiology
- Tuberculosis, Pulmonary -- diagnosis
- Washington
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.